Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from SNY

Chris “Mad Dog” Russo Explains His Radio Philosophy to Dan Patrick

The SiriusXM host says knowledge isn’t the only quality a good talk show host needs to have.

Sports Illustrated

Mets Director Responsible for Bringing Cinema to Baseball Departs From SNY

John DeMarsico made sure Mets games gave viewers an experience like none other in baseball.

Sports Illustrated

Why Bo Bichette Decided to Sign With Mets Over Other Offers

Bo Bichette explains why he chose to sign with the Mets this offseason.

Sports Illustrated

From analysis to the latest developments in health,
read the most diverse news in one place.

Flu Season's Here—This Dividend-Payer Controls the Shot Market

With flu season in full swing, drugmakers are hoping for a short-term tailwind after a lackluster 2025. Sanofi could be the winning ticket.

MarketBeat

Jets Great Bart Scott Pays Emotional Tribute to Former Teammate Nick Mangold

New York Jets great Bart Scott addressed the death of former teammate Nick Mangold during a segment on SNY.

Sports Illustrated

Dupixent Pushes Sanofi's Quarterly Sales Past $14.5 Billion Mark

Sanofi SA (NASDAQ:SNY) reported third-quarter sales of $14.55 billion (12.43 billion euros), beating the consensus of $14.46 billion. Sales increased 2.3% year over year, up 7% in constant currency.

Benzinga

Sanofi Drug Shows Superior Efficacy In Genetic Disease Compared To Current Standard Therapy

Sanofi SA (NASDAQ:SNY) on Wednesday revealed topline data from the ElevAATe phase 2 study of efdoralprin alfa (SAR447537, formerly known as INBRX-101), for alpha-1 antitrypsin deficiency (AATD) emphysema.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Sanofi's Rezurock Approval Stumbles In EU For Chronic Graft-Vs-Host Disease

On Friday, the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) issued a negative opinion for Sanofi SA’s (NASDAQ:SNY) Rezurock (belumosudil).

Benzinga

Sanofi AlphaMedix Study Hits Key Milestones In Phase 2 Study

Sanofi SA (NASDAQ:SNY) on Wednesday released topline data from a phase 2 study evaluating the efficacy and safety of AlphaMedix (212Pb-DOTAMTATE).

Benzinga

Sanofi Expands Insulin Savings Program To Cover All US Patients

The U.S. Food and Drug Administration removed the Risk Evaluation and Mitigation Strategies (REMS) program for Caprelsa (vandetanib), a thyroid cancer medication manufactured by Sanofi SA’s (NASDAQ: SNY) Genzyme Corporation.

Benzinga

FDA Delays Key Sanofi Multiple Sclerosis Drug Decision

On Monday, the U.S. Food and Drug Administration (FDA) extended the review date for Sanofi SA’s (NASDAQ:SNY) new drug application (NDA) of tolebrutinib for non-relapsing, secondary progressive multiple sclerosis (nrSPMS) and to slow disability accumulation independent of relapse activity in adult patients.

Benzinga

Why Is Sanofi Stock Falling Thursday?

On Thursday, Sanofi SA (NASDAQ:SNY) stock tumbled after late-stage trial results for amlitelimab, its potential successor to blockbuster eczema drug Dupixent, failed to match investor expectations, raising fresh doubts about the company’s ability to sustain its dermatology franchise once patent protections expire.

Benzinga

Sanofi Hit With Shock As Flagship Drug Successor Disappoints Investors

French drugmaker Sanofi SA (NASDAQ:SNY) stock fell sharply Thursday after late-stage trial results for amlitelimab, its potential successor to blockbuster eczema drug Dupixent, failed to match investor expectations, raising fresh doubts about the company’s ability to sustain its dermatology franchise once patent protections expire.

Benzinga

New York Radio Host Goes Off On ‘Mad Dog’ Russo After Rant About Mets Broadcaster

“Mad Dog” Russo’s rant about Pete Alonso and a home run call bothered another New York broadcaster.

Sports Illustrated

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Options Corner: Sanofi's Post-Earnings Drama Delivers A Contrarian Discount

With investors concerned about overall economic stability amid the Trump administration's tariff impact, they're not in a particularly generous mood. That may be the lesson learned the hard way by global pharmaceutical giant Sanofi SA (NASDAQ:SNY). Despite delivering an earnings report that offered an encouraging view, it wasn't a perfect…

Sports Illustrated

Mets Reliever Had Saddest Reaction After Learning He’d Been Traded During Game

This was an emotional moment for Jose Butto at the trade deadline.

Benzinga

Sanofi's Q2 Earnings Fall Short On Expectations Despite 21% Jump In Dupixent Sales

Sanofi SA (NASDAQ:SNY) reported second-quarter sales of $11.33 billion (€9.99 billion euros), narrowly missing the consensus of $11.53 billion.

Sports Illustrated

Mets Announcer Reacts Live to Hefty Haul Team Sent to Giants in Tyler Rogers Trade

The Mets' trade package for Rogers included two top-15 prospects.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Sanofi Expands Respiratory Vaccine Portfolio With UK Biotech Buy

Sanofi SA (NASDAQ:SNY) on Tuesday agreed to acquire Vicebio Ltd, a privately held biotechnology company headquartered in London, U.K.

Sports Illustrated

David Wright Had All the Emotions As Mets Retired His No. 5 Jersey

An awesome moment for one of the greatest Mets ever.

Sports Illustrated

Mets vs. Yankees TV Battle Leads to Astonishing Ratings News

How did SNY crush YES so badly in latest Subway Series viewership?

Sports Illustrated

Mets Announcer Keith Hernandez Was So Oblivious to Close Call With Foul Ball in Booth

Keith Hernandez narrowly avoided getting hit in the head by a foul ball while in the SNY booth during the Mets game against the Orioles.

Sports Illustrated

Mets Broadcaster Keith Hernandez Makes It Clear He Doesn’t Work for Free

Weather in Baltimore forced the SNY crew to work a doubleheader.

Sports Illustrated

Mets' Juan Soto Had Funny Reply When Asked About All-Star Snub

Funny, but ... curious.

Sports Illustrated

Mets Pitcher’s Son Adorably Steals Microphone to Give Dad’s Start a Glowing Review

David Roberton’s son was impressed with his performance against the Brewers.

1 2 3 4 5

People

Chris "Mad Dog" Russo

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.